InspireMD (NSPR) Stock Statistics & Valuation Metrics

InspireMD has a market cap or net worth of $88.66M. The enterprise value is $99.83M.

InspireMD has 41,720,660 shares outstanding. The number of shares has decreased by -2.65% in one year.

InspireMD’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -84.61%.

The current PE Ratio of InspireMD is ―. InspireMD’s PEG ratio is 0.47.

In the last 12 months, InspireMD had revenue of 7.01M and earned -32.01M in profits. Earnings per share was -0.76.

In the last 12 months, operating cash flow was -32.51M and capital expenditures -1.57M, giving a free cash flow of -34.08M billion.

InspireMD pays an annual dividend of ―, resulting in a dividend yield of ―

InspireMD upcoming earnings date is Mar 10, 2026, TBA (Confirmed).

InspireMD as a current ratio of 5.28, with Debt / Equity ratio of 3.69%

In the past 12 months, InspireMD has paid 59.00K in taxes.

InspireMD EV to EBITDA ratio is -2.82, with an EV/FCF ratio of -4.03.

InspireMD has $63.40M in cash and marketable securities with $2.37M in debt, giving a net cash position of $61.04M billion.

Gross margin is 24.91%, with operating margin of -478.00%, and net profit margin of -456.63%.

The average price target for InspireMD is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy